Global Industrial Gases Market to Reach US$ 114.5 Bn by 2025 – Persistence Market Research
/
Date13 Mar 2018
New York, March 13, 2018 (GLOBE NEWSWIRE) — Increased energy demand, improving economies and climate control initiatives in both developing and developed nations are resulting... Read More →
SPYR Games Signs Consulting Agreement with Gaming and Esports Investor and Advisor, Stephen A. Crystal, Esq.
/
Date13 Mar 2018
SPYR Games brings domain expertise in esports and growth through engagement with Stephen Crystal and SCCG Management DENVER, March 13, 2018 (GLOBE NEWSWIRE) — SPYR,... Read More →
MVC Capital Announces First Quarter 2018 Results
/
Date13 Mar 2018
PURCHASE, N.Y., March 12, 2018 (GLOBE NEWSWIRE) — MVC Capital, Inc. (NYSE:MVC) (the Company), a publicly traded business development company (BDC) that makes private debt... Read More →
Epizyme Reports Fourth Quarter and Full Year 2017 Operating Results and 2018 Milestones
/
Date13 Mar 2018
First Tazemetostat NDA Submission for Epithelioid Sarcoma Targeted for Fourth Quarter of 2018; Second Tazemetostat NDA Submission for Follicular Lymphoma Targeted for 2019 Multiple Phase... Read More →
Fremsættelse af betinget frivilligt købstilbud
/
Date13 Mar 2018
NASDAQ Copenhagen A/SNikolaj Plads 61007 København K Selskabsmeddelelse nr. 04.2018 Dato:Vor ref.:Telefon: 13.03.2018Alma Lund Høj9870 3005 Fremsættelse af betinget frivilligt købstilbud Nordjyske... Read More →
Sypris Solutions, Inc. to Announce Fourth Quarter Financial Results, Host Conference Call and Webcast on March 20
/
Date13 Mar 2018
LOUISVILLE, Ky., March 12, 2018 (GLOBE NEWSWIRE) — Sypris Solutions, Inc. (NASDAQ/GM: SYPR) will provide an online, real-time webcast and rebroadcast of its conference call... Read More →
Sterk fjárhagsstaða Garðabæjar
/
Date13 Mar 2018
Ársreikningur Garðabæjar fyrir árið 2017, sem lagður var fram á fundi bæjarráðs Garðabæjar í dag, þriðjudaginn 13. mars 2018, lýsir mjög sterkri fjárhagsstöðu sveitarfélagsins. Rekstarafgangur nemur 1.153... Read More →
BioXcel Therapeutics Announces Closing of Initial Public Offering
/
Date13 Mar 2018
BRANFORD, Conn., March 12, 2018 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (“BTI”) (Nasdaq:BTAI), a clinical stage biopharmaceutical development company utilizing novel artificial intelligence to identify... Read More →